½ÃÀ庸°í¼­
»óǰÄÚµå
1775379

¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå : ¿¹Ãø(2025-2030³â)

Surgical Mask Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀåÀº CAGR 6.00%·Î, 2025³â 71¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 95¾ï 3,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿Ü°ú ¼ö¼úÀÇ Áõ°¡, Àα¸ °í·ÉÈ­, Á¤ºÎÀÇ Áö¿øÃ¥, ƯÈ÷ ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®ÃçÁø Áö¿ªÀÌ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ÃËÁø¿äÀΰú Áö¸®Àû Àü¸Á¿¡ ÃÊÁ¡À» ¸ÂÃß°í 2024³â ÀÌÈÄÀÇ µ¥ÀÌÅÍ¿Í ½ÃÀå °³Ã´À» Æ÷ÇÔÇÕ´Ï´Ù.

½ÃÀå ÃËÁø¿äÀÎ

  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÇコÄɾî ÅõÀÚ

Á¤ºÎÀÇ ¿ìÈ£ÀûÀÎ Á¤Ã¥À¸·Î º¸°Ç¿ë ¸¶½ºÅ© ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. »ç¿ìµð¾Æ¶óºñ¾Æ¿Í ¾Æ¶ø¿¡¹Ì¸®Æ®¿Í °°Àº Áö¿ª¿¡¼­´Â ÀÇ·á ÅõÀÚÀ¯Ä¡°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¹Î°üÀÇ ¸·´ëÇÑ ÅõÀÚ·Î µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ 'ºñÀü 2030' ÇÁ·Î±×·¥Àº ÇコÄɾ ¿ì¼±¼øÀ§¸¦ µÎ°í »õ·Î¿î º´¿ø°ú ÷´Ü ÀÎÇÁ¶ó¿¡ ÀÚ±ÝÀ» ÅõÀÔÇϰí ÀÖ½À´Ï´Ù. ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)ÀÇ ÃÖ÷´Ü ½Ã¼³°ú °£¼ÒÈ­µÈ ºñÀÚ ÀýÂ÷·Î µÎ¹ÙÀÌ¿¡¼­ Ä¡·á¸¦ ¹Þ±â À§ÇØ ºñ¿ë È¿À²ÀûÀ̰í Áú ³ôÀº Ä¡·á¸¦ ¿øÇÏ´Â Àü ¼¼°è ȯÀÚµéÀ» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ÀÇ·á ½Ã½ºÅÛÀÇ È®´ë¿¡ µû¶ó ¼ö¼ú¿ë ¸¶½ºÅ©ÀÇ ¼ö¿äµµ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

  • ¹Ì¿ë ¼ö¼úÀÇ Àα⠻ó½Â

¼ºÇü¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. °ú°Å µ¥ÀÌÅÍ´Â Á¦¿ÜµÇ¾úÁö¸¸, ¾ó±¼, ¸Ó¸®, °¡½¿ ¼ö¼ú µî ¹Ì¿ë ¼ö¼úÀÇ Áõ°¡ Ãß¼¼´Â ½ÃÀå ¼ºÀå¿¡ °è¼Ó ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¹ÌÀû °¨°¢À» Çâ»ó½Ã۰íÀÚ ÇÏ´Â ¼ÒºñÀÚÀÇ ¼ö¿ä¿¡ ÈûÀÔ¾î Àü ¼¼°èÀûÀ¸·Î ¼±ÅÃÀû ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹«±Õ ȯ°æÀ» À¯ÁöÇϱâ À§ÇÑ ¼ö¼ú¿ë ¸¶½ºÅ©°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú°í, ÀÌ´Â ½ÃÀå È®´ë¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

  • Àα¸ °í·ÉÈ­

Àü ¼¼°è °í·ÉÈ­´Â ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀåÀ» °ßÀÎÇÏ´Â Å« ¿äÀÎÀÔ´Ï´Ù. Áß±¹¿¡¼­´Â ³ëÀÎ Àα¸ÀÇ Áõ°¡°¡ ¿Ü°ú ¼ö¼úÀÇ Áõ°¡, ƯÈ÷ ½ÉÇ÷°üÁúȯÀÇ Áõ°¡¿Í °ü·ÃÀÌ ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)´Â 2030³â±îÁö ÀÌ·¯ÇÑ »ç·Ê°¡ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀÇ °¡Ã³ºÐ ¼Òµæ Áõ°¡´Â ¹Î°£ ÀǷẸÇèÀ» Æ÷ÇÔÇÑ ÇÁ¸®¹Ì¾ö ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ È®´ë¸¦ °¡´ÉÇÏ°Ô Çϰí, ¼ö¼ú °Ç¼ö Áõ°¡¿Í ¸¶½ºÅ© ¼ö¿ä Áõ°¡¿Í »ó°ü°ü°è°¡ ÀÖ½À´Ï´Ù. ¹Ý¸é ÀϺ»¿¡¼­´Â °í·ÉÈ­°¡ ÁøÇà ÁßÀÌ°í ºñ±³Àû °Ç°­ÇÑ »ýȰ½À°üÀ» À¯ÁöÇϰí Àֱ⠶§¹®¿¡ º¹ÀâÇÑ Áúº´ÀÇ À¯ÇàÀº Á¦ÇÑÀûÀÌÁö¸¸, ±×·³¿¡µµ ºÒ±¸ÇÏ°í ¼ö¼úÀÇ Çʿ伺¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Áö¸®Àû Àü¸Á

  • ºÏ¹Ì

ºÏ¹Ì´Â ¹Ì±¹°ú ij³ª´ÙÀÇ ³ô¾ÆÁø °Ç°­ Àνİú ¾ö°ÝÇÑ °Ç°­ °ü¸® ±âÁØÀ¸·Î ÀÎÇØ ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ëÇü Á¦¾à»çÀÇ Á¸Àç¿Í ÇコÄɾî Àü¹®°¡µéÀÇ ³ôÀº À§»ý¿¡ ´ëÇÑ ±â´ë°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ÀÎÇÁ¶ó°¡ Àß ¹ß´ÞµÇ¾î ÀÖ¾î ÀÓ»ó ÇöÀåÀÇ º¸°Ç¿ë ¸¶½ºÅ© ¼ö¿ä°¡ ¾ÈÁ¤ÀûÀÔ´Ï´Ù.

  • ¾Æ½Ã¾ÆÅÂÆò¾ç

¾Æ½Ã¾ÆÅÂÆò¾ç¿¡´Â Å« ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ÀϺ»¿¡¼­´Â °í·ÉÈ­°¡ ÁøÇàµÇ°í, Áß±¹¿¡¼­´Â ¾Ï, ³úÁ¹Áß µî ÁßÁõ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿Ü°úÀû °³ÀÔ, ³ª¾Æ°¡ ¼ö¼ú¿ë ¸¶½ºÅ©ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸Åë°èÇÐÀû, º¸°ÇÇÐÀû Ãß¼¼·Î º¼ ¶§, ÀÌ Áö¿ªÀº ÇâÈÄ È®´ë°¡ ¿¹»óµÇ´Â Áß¿äÇÑ ½ÃÀåÀÔ´Ï´Ù.

±âŸ Áö¿ª

À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ³²¹Ìµµ ¼¼°è ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯·´Àº ³ôÀº À§»ý ±âÁØ¿¡¼­ ºÏ¹Ì¸¦ ¹Ý¿µÇϰí ÀÖÀ¸¸ç, Áßµ¿Àº ÀÇ·á°ü±¤°ú ÀÎÇÁ¶ó ÅõÀÚ·Î ÀÎÇÑ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¾ÆÇÁ¸®Ä«¿Í ³²¹Ì´Â ÇコÄɾ ´ëÇÑ ÅõÀÚ¿Í ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

º» º¸°í¼­ÀÇ ÁÖ¿ä ÀåÁ¡

  • ÅëÂû·Â ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷º°, ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃá ÁÖ¿ä Áö¿ª ¹× ½ÅÈï Áö¿ªÀ» Æ÷°ýÇÏ´Â »ó¼¼ÇÑ ½ÃÀå ºÐ¼®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï »óȲ : ¼¼°è ÁÖ¿ä ±â¾÷µéÀÌ Ã¤ÅÃÇϰí ÀÖ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí, ÀûÀýÇÑ Àü·«À» ÅëÇÑ ½ÃÀå ħÅõ °¡´É¼ºÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í ±×°ÍµéÀÌ ÇâÈÄ ½ÃÀå °³Ã´À» ¾î¶»°Ô Çü¼ºÇÒ °ÍÀΰ¡¸¦ »ìÆìº¾´Ï´Ù.
  • ½ÇÇà °¡´ÉÇÑ Á¦¾È : ÀλçÀÌÆ®¸¦ Àü·«Àû ÀÇ»ç°áÁ¤¿¡ Ȱ¿ëÇϰí, ¿ªµ¿ÀûÀΠȯ°æ ¼Ó¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¼öÀÍÀ» ¹ß±¼ÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ »ç¿ëÀÚ¿¡ ´ëÀÀ : ½ºÅ¸Æ®¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÀÔ Àü·«, Áö¸®Àû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

  • 2022-2024³â ½ÇÀû µ¥ÀÌÅÍ ¹× 2025-2030³â ¿¹Ãø µ¥ÀÌÅÍ
  • ¼ºÀå ±âȸ, µµÀü°úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× µ¿Ç⠺м®
  • °æÀï»ç Æ÷Áö¼Å´×, Àü·« ¹× ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¸ÅÃâ ¼ºÀå ¹× ¿¹Ãø ±¹°¡¸¦ Æ÷ÇÔÇÑ ºÎ¹® ¹× Áö¿ªº° ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(ƯÈ÷ À繫 ¹× ÁÖ¿ä °³¹ß)

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

  • ½ÃÀå °³¿ä
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • Àü·«Àû Á¦¾È

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ¼¼°èÀÇ ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ·¹º§ 1 ¼ö¼ú¿ë ¸¶½ºÅ©
  • ·¹º§ 2 ¼ö¼ú¿ë ¸¶½ºÅ©
  • ·¹º§ 3 ¼ö¼ú¿ë ¸¶½ºÅ©
  • ¿Ü°ú¿ë N95 ¸¶½ºÅ©
  • Ç×±Õ¡¤Ç×¹ÙÀÌ·¯½º ¼ö¼ú¿ë ¸¶½ºÅ©
  • Ư¼ö ¸¶½ºÅ©

Á¦6Àå ¼¼°èÀÇ ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå : Àç·á ¶Ç´Â Ãþ ±¸¼ºº°

  • ¼Ò°³
  • 2Ãþ
  • 3Ãþ
  • 4Ãþ ÀÌ»ó

Á¦7Àå ¼¼°èÀÇ ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå : À¯Åë ä³Îº°

  • ¼Ò°³
  • ¿Â¶óÀÎ ¼Ò¸Å
  • ¿ÀÇÁ¶óÀÎ
    • º´¿ø ¹× ÇコÄÉ¾î ½Ã¼³ Á¶´Þ
    • ¾à±¹ üÀÎ
    • ÀÇ·á¿ëǰ ÆÇ¸Å¾÷ü

Á¦8Àå ¼¼°èÀÇ ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼Ò°³
  • º´¿ø°ú ¿Ü°ú ¼¾ÅÍ
  • Ä¡°úÀÇ¿ø
  • ¼ÒºñÀÚ
  • »ê¾÷
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¼ö¼ú¿ë ¸¶½ºÅ© ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • Àεµ³×½Ã¾Æ
    • ű¹
    • ±âŸ

Á¦10Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ ¹× Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦11Àå ±â¾÷ °³¿ä

  • 3M Company
  • Kwalitex Healthcare Private Limited
  • Cartel Healthcare Pvt. Ltd.
  • Medline Industries Inc.
  • Magnum Health and Safety Pvt. Ltd.
  • Honeywell International Inc.
  • Kimberly-Clark Corporation
  • Alpha Pro Tech, Ltd.
  • Louis M. Gerson Company, Inc.
  • O & M Halyard, Inc.
  • Cardinal Health, Inc.

Á¦12Àå ºÎ·Ï

  • ÅëÈ­
  • °¡Á¤
  • ±âÁØ ¿¬µµ¿Í ¿¹Ãø ¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ÁÖ¿ä ÀÌÁ¡
  • Á¶»ç ¹æ¹ý
  • ¾à¾î
ksm 25.08.01

The Surgical Mask Market is expected to grow from USD 7.120 billion in 2025 to USD 9.530 billion in 2030, at a CAGR of 6.00%.

The surgical mask market is poised for growth driven by increasing surgical procedures, an aging population, and supportive government initiatives, particularly in regions with robust healthcare infrastructure. This summary focuses on market drivers and geographical outlook, incorporating data and developments from 2024 onward.

Market Growth Drivers

  • Government Initiatives and Healthcare Investment

Favorable government policies are significantly boosting the surgical mask market. In regions like Saudi Arabia and the UAE, medical tourism is surging, supported by substantial investments from public and private sectors. Saudi Arabia's Vision 2030 program prioritizes healthcare, channeling funds into new hospitals and advanced infrastructure. The UAE's state-of-the-art facilities and streamlined visa processes for medical treatment in Dubai attract global patients seeking cost-effective, high-quality care. These developments are expected to drive significant demand for surgical masks as healthcare systems expand.

  • Rising Popularity of Cosmetic Surgeries

The growing demand for cosmetic surgeries is another key driver. While historical data is excluded, the trend of increasing aesthetic procedures, such as facial, head, and breast surgeries, continues to contribute to market growth. The global rise in elective surgeries, driven by consumer demand for aesthetic enhancements, necessitates surgical masks to maintain sterile environments, further fueling market expansion.

  • Aging Population

The global aging population is a major factor propelling the surgical mask market. In China, the rising elderly demographic is linked to increased surgical procedures, particularly for cardiovascular diseases, with the World Health Organization projecting significant growth in such cases through 2030. Rising disposable incomes in these regions enable greater investment in premium healthcare solutions, including private health insurance, which correlates with higher surgical volumes and mask demand. In contrast, Japan's aging population maintains relatively healthy lifestyles, limiting complex disease prevalence but still contributing to surgical needs.

Geographical Outlook

  • North America

North America is expected to maintain a significant share of the surgical mask market, driven by heightened health consciousness and stringent healthcare standards in the United States and Canada. The presence of major pharmaceutical companies and high hygiene expectations among healthcare professionals further support market growth. The region's advanced healthcare infrastructure ensures consistent demand for surgical masks in clinical settings.

  • Asia-Pacific

The Asia-Pacific region presents substantial growth opportunities. Japan's aging population and China's increasing prevalence of severe conditions, such as cancer and strokes, drive the need for surgical interventions and, consequently, surgical masks. These demographic and health trends position the region as a key market for future expansion.

Other Regions

Europe, the Middle East, Africa, and South America also contribute to the global market. Europe mirrors North America in its high hygiene standards, while the Middle East benefits from medical tourism and infrastructure investments. Africa and South America are expected to see growth aligned with increasing healthcare investments and awareness.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Surgical Mask Market Segmentation:

By Product

  • Level 1 Surgical Mask
  • Level 2 surgical Mask
  • Level 3 Surgical Mask
  • Surgical N95 Respirator
  • Antimicrobial/Antiviral Surgical Mask
  • Specialty Masks

By Material or Layer Composition

  • 2-ply
  • 3-ply
  • 4-ply and above

By Distribution Channel

  • Online Retail
  • Offline
  • Hospital and Healthcare Facility Procurement
  • Pharmacy Chains
  • Medical Supply Distributors

By End-User

  • Hospitals & Surgical Centers
  • Dental Clinics
  • Consumers
  • Industries
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Regulatory Framework
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL SURGICAL MASK MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Level 1 Surgical Mask
  • 5.3. Level 2 Surgical Mask
  • 5.4. Level 3 Surgical Mask
  • 5.5. Surgical N95 Respirator
  • 5.6. Antimicrobial/Antiviral Surgical Mask
  • 5.7. Specialty Masks

6. GLOBAL SURGICAL MASK MARKET BY MATERIAL OR LAYER COMPOSITION

  • 6.1. Introduction
  • 6.2. 2-ply
  • 6.3. 3-ply
  • 6.4. 4-ply and above

7. GLOBAL SURGICAL MASK MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online Retail
  • 7.3. Offline
    • 7.3.1. Hospital and Healthcare Facility Procurement
    • 7.3.2. Pharmacy Chains
    • 7.3.3. Medical Supply Distributors

8. GLOBAL SURGICAL MASK MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Surgical Centers
  • 8.3. Dental Clinics
  • 8.4. Consumers
  • 8.5. Industries
  • 8.6. Others

9. GLOBAL SURGICAL MASK MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE LANDSCAPE

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. 3M Company
  • 11.2. Kwalitex Healthcare Private Limited
  • 11.3. Cartel Healthcare Pvt. Ltd.
  • 11.4. Medline Industries Inc.
  • 11.5. Magnum Health and Safety Pvt. Ltd.
  • 11.6. Honeywell International Inc.
  • 11.7. Kimberly-Clark Corporation
  • 11.8. Alpha Pro Tech, Ltd.
  • 11.9. Louis M. Gerson Company, Inc.
  • 11.10. O & M Halyard, Inc.
  • 11.11. Cardinal Health, Inc.

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦